Could This Catalyst That Spark Rivian Stock Gains in 2024
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
The Dow Jones uses price weighting, which gives more influence to higher-priced stocks. This note covers the rationale and implications for investors.
25,255 articlesRivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
Insider stock moves can signal many things. This guide unpacks a high-profile CEO sale, explains what to look for, an...
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
Dutch Bros has shown rapid growth in recent years. This investing guide breaks down how the company wins customers, w...
QuantumScape's solid-state battery efforts could redefine EV charging. This guide digs into what might drive QS stock...
A recent Insider Form 4 reveals Nayax Ltd.'s President sold 4,500 shares after exercising options. Here’s how to read...
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A notable insider maneuver at CareDx drew attention to the stock. This article breaks down the sale, what it means fo...